-
Anti-obesity effects of bioactive compound from natural products: a mechanism-oriented approach focusing on cellular signaling and metabolic regulation
Choon Young Kim Yeungnam University, Republic of Korea 08:50~09:10 -
Semaglutide for obesity treatment and cardiometabolic benefits
Yun Kyung Cho University of Ulsan, Republic of Korea 09:10~09:30 -
Tirzepatide a dual GIP GLP-1 receptor agonist in obesity and metabolic care
Sang-Ho Jo Hallym University, Republic of Korea 09:30~09:50 - Panel Discussion 09:50~10:20
-
Discrepant Effect of High-Density Lipoprotein Cholesterol on the Hematologic Malignancy Risk: A Nationwide Cohort Study
Su Youn Nam Kyungpook National University, Republic of Korea 14:50~15:05 -
Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function
Mee Kyoung Kim The Catholic University of Korea, Republic of Korea 15:05~15:20 -
Association Between Lipoprotein (a) Levels and Coronary Artery Disease (CAD) Among Patients With or Without CAD Family History
Hayato Tada Kanazawa University, Japan 15:20~15:35 -
Investigation of the Influence of Lipoprotein(a) and Oxidized Lipoprotein(a) on Plasminogen Activation and Fibrinolysis
Wen-Liang Song Brown University Health, USA 15:35~15:50 -
Fatty Acids in Childhood Obesity: A Link Between Nutrition, Metabolic Alterations and Cardiovascular Risk
Belen Davico University of Buenos Aires, Argentina 15:50~16:05 - Discussion 16:05~16:20
